Long Island Press

Floral Park Board of Trustees Nov. 5 meeting reports

As you may know, if you’ve been following our Board meetings, biweekly Friday E-Village Items (by email or on the Village ...

ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025

The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green CNS(Vafidemstat) Received feedback ...

Camden Property Trust (CPT) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call November 7, 2025 11:00 AM ESTCompany ParticipantsKimberly Callahan - Senior Vice President of ...
The Manila Times

Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...